FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/01/079516 [Registered on: 27/01/2025] Trial Registered Prospectively
Last Modified On: 25/01/2025
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Other 
Public Title of Study   Zandu Abhayarishta in the management of Arsha (Hemorrhoids) 
Scientific Title of Study   Evaluation of Clinical efficacy of Zandu Abhayarishta in the Management of Arsha (Hemorrhoids) with/without Associated Symptoms 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
N/A  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DRSANJAY SRIVASTAVA 
Designation  Associate Professor 
Affiliation  DR.S.R. RAJASTHAN AYURVED UNIVERSITY JODHPUR 
Address  Room No.162, Bharadwaj Bhawan, PGIA, DSRRAU, Jodhpur RAJASTHAN India

Jodhpur
RAJASTHAN
342037
India 
Phone  09414410383  
Fax    
Email  sanjayphyayu@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DRSANJAY SRIVASTAVA 
Designation  Associate Professor 
Affiliation  DR.S.R. RAJASTHAN AYURVED UNIVERSITY JODHPUR 
Address  Room No.162, Bharadwaj Bhawan, PGIA, DSRRAU, Jodhpur RAJASTHAN India


RAJASTHAN
342037
India 
Phone  09414410383  
Fax    
Email  sanjayphyayu@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DRSANJAY SRIVASTAVA 
Designation  Associate Professor 
Affiliation  DR.S.R. RAJASTHAN AYURVED UNIVERSITY JODHPUR 
Address  Room No.162, Bharadwaj Bhawan, PGIA, DSRRAU, Jodhpur RAJASTHAN India


RAJASTHAN
342037
India 
Phone  09414410383  
Fax    
Email  sanjayphyayu@gmail.com  
 
Source of Monetary or Material Support  
R&D Healthcare Division Emami Ltd, 13 BT Road, Belgharia, Kolkata – 700056 Ph. No 91-033 6622317 
 
Primary Sponsor  
Name  Healthcare Division Emami Ltd 
Address  Sr. Manager, Medical Research R&D Healthcare Division Emami Ltd, 13 BT Road, Belgharia, Kolkata – 700056 Ph. No 91-033 66223176 
Type of Sponsor  Pharmaceutical industry-Indian 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL  
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DrSanjay Srivastava  Sanjeevani Ayurveda Hospital,DSRRAU  OPD Block, ROOM NO,14 Jodhpur RAJASTHAN
Jodhpur
RAJASTHAN 
09414410383

sanjayphyayu@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee - PGIA Jodhpur   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:K928||Other specified diseases of the digestive system. Ayurveda Condition: ARSAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugClassical(1) Medicine Name: Haritaki, Reference: Bhavprakash Nighantu, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 650(mg), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 30 Days, anupAna/sahapAna: Yes(details: with Abhayarishta), Additional Information: -
2Intervention ArmDrugClassical(1) Medicine Name: ABHAYARISHTA, Reference: Bharat Bhaishajya Ratnakar, Route: Oral, Dosage Form: Arishta, Dose: 20(ml), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 30 Days, anupAna/sahapAna: Yes(details: water), Additional Information: NIL
3Comparator ArmDrugClassical(1) Medicine Name: ABHAYARISHTA, Reference: Bharat Bhaishajya Ratnakar, Route: Oral, Dosage Form: Arishta, Dose: 20(ml), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 30 Days, anupAna/sahapAna: Yes(details: with lukewarm water), Additional Information: -
 
Inclusion Criteria  
Age From  16.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patients suffering from following minimum 3 symptoms from category A and B of symptoms associated with Arsha will be selected for this study.
Category A:
1. Swelling (Sotha)
2. Bleeding /Fissure (Raktashrava/ Parikartika)
3. Perianal Pain (Shula)
4. Burning (Daha)
5. Itching/ irritation (kandu)
Category B:
6. Loss of appetite (Kshudhanash)
7. Distended abdomen (Anaha)
8. Flatulence (Adhmana)
9. Acidity (Amlodgar)
10. Kosthabadhata (Constipation)
 
 
ExclusionCriteria 
Details  1.Patients suffering from 3rd /4th degree piles
2.Patients who develop secondary complication of
Colitis, intestinal obstruction etc.
3.Any other serious illness e.g., Hepatic/ renal
failure/severe anemia.
4.Known hypersensitivity or allergy to one or more
of the herbal ingredients
5.Other debilitating neurological or psychiatric
disorders
 
 
Method of Generating Random Sequence   Adaptive randomization, such as minimization 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Reduction in Haemorrhoidal Symptoms: Evaluate the decrease in severity of symptoms such as pain, bleeding, prolapse, and itching as assessed using a validated grading or symptom severity scale over the study period.  45days 
 
Secondary Outcome  
Outcome  TimePoints 
Improvement in Quality of Life (QoL): Assess changes in patient-reported QoL using a hemorrhoid-specific QoL questionnaire.
Reduction in Recurrence Rate: Measure the recurrence of hemorrhoidal symptoms within the follow-up period.
Improvement in Bowel Habits: Evaluate changes in stool consistency, frequency, and straining using a standardized bowel habit questionnaire.
Safety Assessment: Monitor adverse effects or tolerability issues with Zandu Abhayarishta and Haritaki.
Overall Treatment Satisfaction: Patient-reported satisfaction with the treatment modality, based on a Likert scale or similar metric. 
45 days 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   06/02/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="3"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

·      Arsha  are swollen blood vessels of the Anus &lower rectum.1 Anyone at any age can be affected by haemorrhoids. It is very common, with about 50% of people experiencing them at some time in their life. However, it is mostly observed in elderly people and during pregnancy. Ayurveda the ancient science of life, has described it as anorectal disorders in very detailed manner.2arivat pranan shrunati hinasti iti arshaha”.

·      Zandu Abhayarishta is a well-known Classical Ayurvedic product from Ayurvedic text “Bharat Bhaishajya Ratnakar”, being marketed in India from more than five decades for the management of the symptoms associated with piles, indigestion & constipation. Zandu Abhayarishta contains Haritaki, Vidanga, Madhuka, Draksha, Dhanyaka,Sunthi,  Indravaruni, Trivrit along with other Ayurvedic ingredients which are well known to have analgesic, anti-inflammatory, wound healing and antimicrobial digestive, laxative properties.

 Keeping all these facts it is decided to study on “Evaluation of Clinical efficacy of Zandu Abhayarishta in the Management of Arsha (Hemorrhoids) with/without Associated Symptoms.”

 
Close